Press release
Monkeypox Market to Reach USD 264 Million by 2031 Amid Global Vaccine and Diagnostic Expansion
Monkeypox Market
The Monkeypox market is growing steadily due to increased global surveillance and early diagnostic adoption, as per our analysis. Governments are investing in vaccine stockpiling, especially JYNNEOS, to strengthen outbreak preparedness.
Emerging markets are expanding access through partnerships with the WHO, Gavi, and the Africa CDC. Ongoing research into next-gen vaccines and antivirals is creating new commercial opportunities.
Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/monkeypox-market?jd
Strategic Partnerships and Global M&A Developments Reshaping the Monkeypox Market Landscape
• Bavarian Nordic secures major U.S. vaccine order: In May 2025, Bavarian Nordic received a USD 63 million federal contract to supply bulk JYNNEOS vaccine doses, reflecting the U.S. government's growing investment in domestic monkeypox preparedness and public health stockpiling.
• Gavi-Africa CDC vaccine procurement partnership: In June 2025, Gavi and Africa CDC jointly facilitated the purchase of 5,000 monkeypox vaccine doses, strengthening outbreak response capacity across African regions.
• Tonix Pharmaceuticals partners on novel poxvirus vaccine research: In July 2025, Tonix initiated a collaboration with Kenya Medical Research Institute to advance its TNX-801 vaccine candidate for monkeypox and smallpox through preclinical and Phase I development.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/monkeypox-market?jd
Competitive Landscape: Key Companies Shaping the Global Monkeypox Market
The global Monkeypox market features a mix of multinational pharmaceutical giants and specialized biotech firms working to expand access to vaccines, antivirals, and diagnostics.
Leading the space is Bavarian Nordic A/S, known for its JYNNEOS vaccine, alongside Emergent BioSolutions Inc. and SIGA Technologies, Inc., both active in biodefense and outbreak preparedness.
Companies like Pfizer Inc., Teva Pharmaceuticals USA, Inc., and Sun Pharmaceutical Industries Ltd. are leveraging their global distribution networks to support public health responses.
Meanwhile, regional players such as Wellona Pharma, Zuche Pharmaceuticals, and Sambria Pharmaceuticals are contributing to market growth through affordable generics and localized supply.
With ongoing innovation and global partnerships, these companies are driving the evolution of Monkeypox prevention and treatment worldwide.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=monkeypox-market?jd
Regional Market Trends Highlight Evolving Monkeypox Response Across Global Health Systems
• North America retains its leading position, supported by consistent vaccine demand, federal purchasing programs, and widespread diagnostic infrastructure upgrades.
• Europe continues to show moderate growth, focusing on regional stockpile coordination and improved cross-border disease surveillance frameworks.
• In Asia-Pacific, the market is evolving with regulatory progress, pilot immunization rollouts, and increased public sector interest in domestic production.
• Latin America, the Middle East, and Africa are seeing gradual expansion, led by donor-backed health programs, improved disease monitoring, and region-specific vaccine access models.
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Monkeypox Market to Reach USD 264 Million by 2031 Amid Global Vaccine and Diagnostic Expansion here
News-ID: 4103259 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Difficult To Express Proteins Market Hits New High | Sino Biological Inc., Therm …
Overview of the Difficult to Express Proteins Market
The Difficult to Express Proteins Market focuses on a specialized segment of the biotechnology industry that addresses the challenges of producing proteins that are inherently complex to synthesize in sufficient quantities and with functional activity in conventional expression systems. These proteins play a critical role in numerous biomedical and pharmaceutical research applications, including drug discovery, protein therapeutics, and disease diagnostics. Difficult to express…
Ablation Catheters Market Poised for Growth, Expected to Reach USD 10.33 Billion …
Overview of the Ablation Catheters Market
The Ablation Catheters Market is a critical segment within the medical devices industry, focused on minimally invasive therapies used to treat cardiac arrhythmias and other medical conditions. Ablation catheters are specialized devices that deliver energy (such as radiofrequency, cryothermal, pulse field, or microwave) to targeted areas inside the body, destroying abnormal tissue responsible for dysfunctional electrical conduction or other pathologies. The adoption of ablation catheters…
Vocal Fold Augmentation Market Valuation Projected at US$2.64 Billion by 2031, R …
Overview of the Vocal Fold Augmentation Market
The vocal fold augmentation market is witnessing significant growth driven by the increasing prevalence of vocal fold disorders worldwide and the rising demand for effective minimally invasive treatments. Vocal fold augmentation is a specialized medical procedure aimed at improving vocal function in patients suffering from glottic insufficiency, caused by conditions such as vocal fold paralysis, atrophy, or scarring. These disorders lead to symptoms like…
US Algae Omega-3 Supplements Market Growth Fueled by Sustainable and Plant-Based …
Algae Omega 3 Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.7 billion by 2030 and is expected to grow with a CAGR of 4.5% during the forecast period 2024-2031.
The Algae omega-3 Market takes center stage in DataM Intelligence's latest in-depth analysis, where expert researchers apply advanced analytics and strategic foresight to deliver unmatched market intelligence. This comprehensive report offers a detailed examination of the…
More Releases for Monkeypox
Monkeypox Market Size, Share, and Growth Opportunities 2029
This Monkeypox Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain…
Monkeypox Treatment Market Is Estimated To Witness High Growth Owing To Increase …
Market Overview:
Monkeypox is an orthopoxvirus that causes rash and skin lesions in humans. The current outbreak has highlighted the need for effective treatments to address monkeypox symptoms and complications.
Market Dynamics:
The Monkeypox Treatment Market is anticipated to witness significant growth over the forecast period, driven by increased monkeypox cases globally. According to the World Health Organization (WHO), as of October 2022, there have been over 77,000 confirmed monkeypox cases across 110…
Global Monkeypox Testing Market Size
According to a new market research report published by Global Market Estimates, the Global Monkeypox Testing Market is expected to grow at a CAGR of 4.5% from 2023 to 2028.
The demand for effective diagnostics in the monkeypox testing market is driven by increasing outbreaks and public health emergencies. Growing awareness among governments and healthcare organizations regarding monitoring and containment boosts market growth. Advanced test kits enable accurate detection and differentiation,…
Monkeypox Testing Market - Unmasking Monkeypox: Accurate Diagnostic Solutions
Newark, New Castle, USA - new report, titled Monkeypox Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Monkeypox Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Monkeypox Testing market. The report offers an overview of the market, which…
Monkeypox Market Research: Market Segmentation and Competitive Analysis
When any business seek to lead the market or make a mark in the market as a fresh emergent, market research report is always central. A comprehensive Monkeypox Market report encompasses a market data that provides a detailed analysis of the ABC industry and its impact based on applications and different geographical regions. The report gives current as well as upcoming technical and financial details of the industry to 2027.…
Europe to Spend USD 18 Million in Monkeypox Testing by the End of 2023; More tha …
According to Arizton's latest research report, the Europe monkeypox testing market to spend USD 18 million by the end of 2023. Growing development of rapid testing methods, advancements in PCR technology, and increasing collaborations among the vendors are the growing trends in the market.
There are only a few MPX test kits available in the market. However, governments make efforts to control the virus due to its rapid spread across…
